首页> 外国专利> HIGHLY MODULAR BIEPITOPIC AND BISPECIFIC CAR-T CELLS FOR CANCER IMMUNOTHERAPY

HIGHLY MODULAR BIEPITOPIC AND BISPECIFIC CAR-T CELLS FOR CANCER IMMUNOTHERAPY

机译:用于癌症免疫治疗的高度模块化的双表位和双特异性CAR-T细胞

摘要

Provided herein are biepitopic or bispecific chimeric antigen receptors. The chimeric antigen receptors comprise a combination of single domain antibody mimics. The single domain antibody mimics may be monobodies, affibodies, or DARPins. The disclosed chimeric antigen receptors may recognize two different epitopes of the same tumor antigen. For example, the chimeric antigen receptor may recognize two different epitopes of HER-2 or EGFR. The disclosed chimeric antigen receptors may recognize two epitopes of two different tumor antigens. For example, the chimeric antigen receptor may recognize HER-2 and EGFR. The disclosed chimeric antigen receptors may be expressed in immune cells for use in cancer immunotherapy.
机译:本文提供了双表位或双特异性嵌合抗原受体。嵌合抗原受体包含单结构域抗体模拟物的组合。单域抗体模拟物可以是单克隆抗体,亲和抗体或DARPins。所公开的嵌合抗原受体可以识别相同肿瘤抗原的两个不同表位。例如,嵌合抗原受体可以识别HER-2或EGFR的两个不同表位。所公开的嵌合抗原受体可以识别两种不同肿瘤抗原的两个表位。例如,嵌合抗原受体可以识别HER-2和EGFR。所公开的嵌合抗原受体可以在用于癌症免疫疗法的免疫细胞中表达。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号